m3 inc (2413:Tokyo)
Transactions by M3 INC (2413) in the last 6 months
Cyfuse Biomedical K.K. announced that it has received ¥1,400,000,000 in its series B round of funding on February 27, 2015. The transaction included participation from CYBERDYNE Inc., Daiwa Corporate Investment Co., Ltd., DBJ Capital Co., Ltd., JAFCO Co., Ltd., The Japan Science and Technology Agency, JT financial service Co., Ltd., M3, Inc., Mitsubishi UFJ Capital Co., Ltd., Shibuya Kogyo Co., Ltd. and returning investors, Nippon Venture Capital Co., Ltd., NISSAY CAPITAL ...
Daiwa Corporate Investment Co., Ltd.
DBJ Capital Co., Ltd.
JAFCO Co., Ltd.
Japan Science And Technology Agency
Mitsubishi UFJ Capital Co. Ltd.
Nippon Venture Capital Co., Ltd.
Nissay Capital Co.,Ltd
Shibuya Kogyo Co., Ltd.
The University of Tokyo Edge Capital Co., Ltd.
M3, Inc. (TSE:2413) entered into a share purchase agreement to acquire 90.9% stake in NEUES Co., Ltd. from a group of shareholders for approximately ¥180 million on December 19, 2014. The sellers include 12 shareholders including Toshiaki Amamoto, K.K. Random Square and Mediscience Planning Inc. M3, Inc. will acquire 1,406 shares in the transaction. NEUES Co reported total assets of ¥2.56 billion, net assets of ¥689 million, revenues of ¥4.04 billion, net loss of ¥23 ...
Mediscience Planning Inc.